blog posts Drugs with multiple targets show promise against myotonic dystrophy type 1 Nov 9, 2015 11:30 am by Diana YatesResearch Share on Facebook Tweet Email Images Researchers have added new capabilities to an experimental drug agent that previously defeated only one of DM1’s many modes of action. Their retooled compounds interrupt the disease’s pathology in three ways. Share on Facebook Tweet Email
